Dr Jedd Wolchok closing in on this Jan 2018 presentation .....and who knows, but Amgen, Regeneron and Surface were added sponsors and how will some BPs open up their overseas $$$$ to Peregrine Pharmaceuticals by the end of this conference ?
T cell Dysfunction, Cancer and Infection (A3)
Scientific Organizers: Daniel C. Douek, W. Nicholas Haining and Jedd D. Wolchok
January 16—20, 2018 Beaver Run Resort, Breckenridge, Colorado, USA
Sponsored by Amgen Inc., Incyte Corporation, Juno Therapeutics, Regeneron Pharmaceuticals, Inc., Surface Oncology and TESARO, Inc.